0002088062-25-000002.txt : 20251016 0002088062-25-000002.hdr.sgml : 20251016 20251016100755 ACCESSION NUMBER: 0002088062-25-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251016 DATE AS OF CHANGE: 20251016 EFFECTIVENESS DATE: 20251016 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mekiri Bio, Inc. CENTRAL INDEX KEY: 0002088062 ORGANIZATION NAME: EIN: 393572739 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-561035 FILM NUMBER: 251396686 BUSINESS ADDRESS: STREET 1: 68 HARRISON AVENUE STREET 2: SUITE 605, PMB 653323 CITY: BOSTON STATE: MA ZIP: 02111 BUSINESS PHONE: 617-203-8458 MAIL ADDRESS: STREET 1: 68 HARRISON AVENUE STREET 2: SUITE 605, PMB 653323 CITY: BOSTON STATE: MA ZIP: 02111 D 1 primary_doc.xml X0708 D LIVE 0002088062 Mekiri Bio, Inc. 68 HARRISON AVENUE SUITE 605, PMB 653323 BOSTON MA MASSACHUSETTS 02111 617-203-8458 DELAWARE None None Corporation true 2025 Debbie Lin 68 Harrison Avenue Suite 605, PMB 653323 Boston MA MASSACHUSETTS 02111 Executive Officer Anita DiFazio 68 Harrison Avenue Suite 605, PMB 653323 Boston MA MASSACHUSETTS 02111 Executive Officer Corey McCann 68 Harrison Avenue Suite 605, PMB 653323 Boston MA MASSACHUSETTS 02111 Director Aaron DiAntonio 68 Harrison Avenue Suite 605, PMB 653323 Boston MA MASSACHUSETTS 02111 Director Biotechnology Not Applicable 06b false 2025-08-25 false true Simple Agreement for Future Equity false 0 2000000 1000000 1000000 false 1 0 0 0 Other than the payment of salaries and other compensation benefits and reimbursement of expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering. false Mekiri Bio, Inc. /s/ Debbie Lin Debbie Lin President 2025-10-16